These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Mutational status of EGFR and KIT in thymoma and thymic carcinoma. Yoh K, Nishiwaki Y, Ishii G, Goto K, Kubota K, Ohmatsu H, Niho S, Nagai K, Saijo N. Lung Cancer; 2008 Dec; 62(3):316-20. PubMed ID: 18448188 [Abstract] [Full Text] [Related]
23. p16INK4, pRB, p53 and cyclin D1 expression and hypermethylation of CDKN2 gene in thymoma and thymic carcinoma. Hirabayashi H, Fujii Y, Sakaguchi M, Tanaka H, Yoon HE, Komoto Y, Inoue M, Miyoshi S, Matsuda H. Int J Cancer; 1997 Nov 27; 73(5):639-44. PubMed ID: 9398039 [Abstract] [Full Text] [Related]
24. Frequent intra-tumoural heterogeneity of promoter hypermethylation in malignant melanoma. Rastetter M, Schagdarsurengin U, Lahtz C, Fiedler E, Marsch WCh, Dammann R, Helmbold P. Histol Histopathol; 2007 Sep 27; 22(9):1005-15. PubMed ID: 17523078 [Abstract] [Full Text] [Related]
26. Epidermal growth factor receptor expression in invasive thymoma. Henley JD, Koukoulis GK, Loehrer PJ. J Cancer Res Clin Oncol; 2002 Mar 27; 128(3):167-70. PubMed ID: 11935304 [Abstract] [Full Text] [Related]
27. Apoptosis, bcl-2 protein, and Fas antigen in thymic epithelial tumors. Tateyama H, Eimoto T, Tada T, Inagaki H, Hattori H, Takino H. Mod Pathol; 1997 Oct 27; 10(10):983-91. PubMed ID: 9346177 [Abstract] [Full Text] [Related]
28. Close localization of DAP-kinase positive tumour-associated macrophages and apoptotic colorectal cancer cells. Schneider-Stock R, Kuester D, Ullrich O, Mittag F, Habold C, Boltze C, Peters B, Krueger S, Hintze C, Meyer F, Hartig R, Roessner A. J Pathol; 2006 May 27; 209(1):95-105. PubMed ID: 16575786 [Abstract] [Full Text] [Related]
29. Expression of PTEN and its pseudogene PTENP1, and promoter methylation of PTEN in non-tumourous thymus and thymic tumours. Masunaga A, Omatsu M, Kunimura T, Uematsu S, Kamio Y, Kitami A, Miyagi Y, Hiroshima K, Suzuki T. J Clin Pathol; 2017 Aug 27; 70(8):690-696. PubMed ID: 28119349 [Abstract] [Full Text] [Related]
30. Frequent silencing of RASSF1A by DNA methylation in thymic neuroendocrine tumours. Kajiura K, Takizawa H, Morimoto Y, Masuda K, Tsuboi M, Kishibuchi R, Wusiman N, Sawada T, Kawakita N, Toba H, Yoshida M, Kawakami Y, Naruto T, Imoto I, Tangoku A, Kondo K. Lung Cancer; 2017 Sep 27; 111():116-123. PubMed ID: 28838380 [Abstract] [Full Text] [Related]
31. Degree of malignancy of thymic epithelial tumors in terms of nuclear DNA content and nuclear area. An analysis of 39 cases. Asamura H, Nakajima T, Mukai K, Noguchi M, Shimosato Y. Am J Pathol; 1988 Dec 27; 133(3):615-22. PubMed ID: 3202120 [Abstract] [Full Text] [Related]
32. Immunohistochemical staining for bcl-2 and mcl-1 in intrathyroidal epithelial thymoma (ITET)/carcinoma showing thymus-like differentiation (CASTLE) and cervical thymic carcinoma. Dorfman DM, Shahsafaei A, Miyauchi A. Mod Pathol; 1998 Oct 27; 11(10):989-94. PubMed ID: 9796728 [Abstract] [Full Text] [Related]
38. Epstein-Barr virus genome in thymoma and thymic lymphoid hyperplasia. McGuire LJ, Huang DP, Teoh R, Arnold M, Wong K, Lee JC. Am J Pathol; 1988 Jun 27; 131(3):385-90. PubMed ID: 2837902 [Abstract] [Full Text] [Related]
39. Aberrant methylation of APC, MGMT, RASSF2A, and Wif-1 genes in plasma as a biomarker for early detection of colorectal cancer. Lee BB, Lee EJ, Jung EH, Chun HK, Chang DK, Song SY, Park J, Kim DH. Clin Cancer Res; 2009 Oct 01; 15(19):6185-91. PubMed ID: 19773381 [Abstract] [Full Text] [Related]
40. Aberrant gene promoter methylation in plasma cell dyscrasias. Martin P, Garcia-Cosio M, Santon A, Bellas C. Exp Mol Pathol; 2008 Jun 01; 84(3):256-61. PubMed ID: 18410922 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]